Search Results

240 results for dgse

Positive Clinical Results Put Nkarta Stock on the Fast Track

NKTX stock is a fast mover, and a recent share-price bump came in the wake of exciting data from a “killer cell” anti-cancer research program.

Here Are a Couple Billion Reasons to Hold Novavax Stock

NVAX stock just came down to an attractive price, and the future looks bright as Novavax continues its expansion into international markets.

With Ocugen Stock: Follow The Lead of Traders and ‘Sell The News’

With its chances of experiencing another sharp slide in price likely. If you own OCGN stock today, cash out ASAP to avoid holding the bag.…

Are Children the Solution to Novavax’s Vaccine Problem?

Canada’s vaccination rate is about to pass the U.S. That does not bode well for Novavax and NVAX stock. Are children the company’s savior?

What Will the Stock Market Do Today? 3 Big Stories to Watch.

So what will the stock market do today? All eyes are on an update to the Elon Musk Bitcoin saga and NVAX stock.

3 Coronavirus Stocks to Go on the Defensive

The pandemic shows no signs of slowing, it’s time to use any signs of weakness in coronavirus stocks as a buying opportunity.

Vaccine Race Is Catching up to Moderna Stock but Outlook Is Solid

Moderna stock is trading at 16 times forward price-to-earnings, quite an unrealistic multiple, considering the vaccine race is tightening.

Why Moderna Stock Looks Quite Risky

Data from the Phase 1 trial of Moderna’s coronavirus vaccine was mixed, making MRNA stock risky at its current levels.

Slim Vaccine Chances Make iBio Stock Too Speculative Here

Every investor is betting on a vaccine. Unfortunately, the case for IBIO stock is simply too speculative, as its trials remain under wraps.

Why CureVac Might Soar From Here

The coronavirus vaccine play is crowded and CureVac stock needs to win more deals to get noticed

Vaccine Backlog Raises New Questions About Moderna

As one of the leaders in the Covid-19 vaccine race, Moderna’s success boosted MRNA stock. But with real-time obstacles coming into the picture, the narrative…

7 Biotech Stocks to Buy Amid the Delta Variant’s Onslaught

You may have thought the moment of relevancy for these biotech stocks was over, but the Delta variant has changed their prospects.

[Weekly Roundup] Market Rout: What to Do When Others Are Fearful

Stock market routs like this are miserable events. They sow widespread financial pain and suffering… along with a heaping dose of anxiety. But at the…

Why Wells Fargo & Co (WFC) Stock Can’t Climb Out of This Hole

WFC stock may be up 36% since October, but a double-dose of bad news for Wells Fargo this week suggests it can’t escape its checkered…

Want to Play Renewable Energy? Focus on the New YieldCos

Just like MLPs & REITs, YieldCos can a dose of high dividends to your portfolio. Here’s a look at how they work and why they’re…

Paul Krugman May Be the World’s Last Flat Earth Economist

Dr. Paul Krugman’s ideas on how to turn the economy around could use a little dose of reality, and the correct way to move forward…

Novavax (NVAX) Stock Pops Ahead of FDA Approval

NVAX stock has risen nearly 10% in the past five trading sessions on expectations that the FDA is going to approve its Covid-19 vaccine.

The Pandemic Is Not Over, And Novavax Is a Strong Contender 

Despite the delays in FDA approval, Novavax has made strong strides in the industry, making NVAX stock is a great pharma stock to buy.

Inovio Stock Will Tread Water Working on a Coronavirus Vaccine

Inovio’s COVID-19 vaccine faces huge hurdles. INO stock will tread water until its manufacturing and financing issues are overcome.

SRNE Stock: Sorrento Therapeutics Pops on Plans to Launch Drug Trials

Sorrento Therapeutics just announced plans to launch human trials of its antibody drug. Here’s why else SRNE stock is rallying.

7 Highly Rated Pharmaceutical Stocks for Q4

Investors are banking on an upsurge in pharmaceutical stocks once various vaccines and other therapies gain commercial approval from the U.S. Food and Drug Administration…

GlaxoSmithKline plc (ADR) (GSK) Seeks FDA Approval for New Shingles Vaccine

GlaxoSmithKline (GSK), a healthcare company, is seeking approval from the U.S. Food and Drug Administration for a shingles vaccine.

4 Electrical Equipment Stocks to Sell Now

This week, 4 Electrical Equipment stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

Why BioNTech Is the Better Biotech Buy

If you’re trying to decide who is the real winner out of the Pfizer and BioNTech partnership, BNTX takes the cake — and here’s why.

8 – 10 of 240 results